172 related articles for article (PubMed ID: 36283891)
1. Therapeutic optimization in head and neck radiotherapy planning: Advocacy for
Nevesny S; Flaus A; Ailloud A; Sotton S; Prevot N; Guy JB; Magné N
Bull Cancer; 2022 Dec; 109(12):1262-1268. PubMed ID: 36283891
[TBL] [Abstract][Full Text] [Related]
2. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
[TBL] [Abstract][Full Text] [Related]
3. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
4. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
5. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
[TBL] [Abstract][Full Text] [Related]
7. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
8. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
9. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
Perez-Romasanta LA; Bellon-Guardia M; Torres-Donaire J; Lozano-Martin E; Sanz-Martin M; Velasco-Jimenez J
Clin Transl Oncol; 2013 Apr; 15(4):283-93. PubMed ID: 22865325
[TBL] [Abstract][Full Text] [Related]
10. Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT.
Niyazi M; Landrock S; Elsner A; Manapov F; Hacker M; Belka C; Ganswindt U
Radiat Oncol; 2013 Jul; 8():180. PubMed ID: 23848981
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
[TBL] [Abstract][Full Text] [Related]
12. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.
Kajitani C; Asakawa I; Uto F; Katayama E; Inoue K; Tamamoto T; Shirone N; Okamoto H; Kirita T; Hasegawa M
J Radiat Res; 2013 Jul; 54(4):671-8. PubMed ID: 23287772
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
[TBL] [Abstract][Full Text] [Related]
15. Use of
Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
[No Abstract] [Full Text] [Related]
16. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
Walter F; Jell C; Zollner B; Andrae C; Gerum S; Ilhan H; Belka C; Niyazi M; Roeder F
Strahlenther Onkol; 2021 Sep; 197(9):780-790. PubMed ID: 33104815
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers.
Syed M; Flechsig P; Liermann J; Windisch P; Staudinger F; Akbaba S; Koerber SA; Freudlsperger C; Plinkert PK; Debus J; Giesel F; Haberkorn U; Adeberg S
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2836-2845. PubMed ID: 32447444
[TBL] [Abstract][Full Text] [Related]
18. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
19. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
[TBL] [Abstract][Full Text] [Related]
20. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
